These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8540348)

  • 61. Molecular basis for substrate recognition and drug resistance from 1.1 to 1.6 angstroms resolution crystal structures of HIV-1 protease mutants with substrate analogs.
    Tie Y; Boross PI; Wang YF; Gaddis L; Liu F; Chen X; Tozser J; Harrison RW; Weber IT
    FEBS J; 2005 Oct; 272(20):5265-77. PubMed ID: 16218957
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Influence of flanking sequences on the dimer stability of human immunodeficiency virus type 1 protease.
    Wondrak EM; Louis JM
    Biochemistry; 1996 Oct; 35(39):12957-62. PubMed ID: 8841142
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Rational engineering of activity and specificity in a serine protease.
    Dang QD; Guinto ER; di Cera E
    Nat Biotechnol; 1997 Feb; 15(2):146-9. PubMed ID: 9035139
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of the HIV-1 and HIV-2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag-Pol polyproteins.
    Tözsér J; Bláha I; Copeland TD; Wondrak EM; Oroszlan S
    FEBS Lett; 1991 Apr; 281(1-2):77-80. PubMed ID: 2015912
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Substrate cleavage by HIV-1 proteinase.
    Jupp RA; Richards AD; Phylip LH; Kay J; Konvalinka J; Strop P; Kostka V; Scarborough PE; Farmerie WG; Dunn BM
    Adv Exp Med Biol; 1991; 306():461-7. PubMed ID: 1812743
    [No Abstract]   [Full Text] [Related]  

  • 66. Real-time measurements of dark substrate catalysis.
    Xie D; Suvorov L; Erickson JW; Gulnik AS
    Protein Sci; 1999 Nov; 8(11):2460-4. PubMed ID: 10595550
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays.
    Dreyer GB; Lambert DM; Meek TD; Carr TJ; Tomaszek TA; Fernandez AV; Bartus H; Cacciavillani E; Hassell AM; Minnich M
    Biochemistry; 1992 Jul; 31(29):6646-59. PubMed ID: 1637805
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Protease activation of split green fluorescent protein.
    Callahan BP; Stanger MJ; Belfort M
    Chembiochem; 2010 Nov; 11(16):2259-63. PubMed ID: 20945451
    [No Abstract]   [Full Text] [Related]  

  • 69. Thermodynamic linkage between the binding of protons and inhibitors to HIV-1 protease.
    Trylska J; Antosiewicz J; Geller M; Hodge CN; Klabe RM; Head MS; Gilson MK
    Protein Sci; 1999 Jan; 8(1):180-95. PubMed ID: 10210196
    [TBL] [Abstract][Full Text] [Related]  

  • 70. HIV-1 protease: structure, dynamics, and inhibition.
    Louis JM; Ishima R; Torchia DA; Weber IT
    Adv Pharmacol; 2007; 55():261-98. PubMed ID: 17586318
    [No Abstract]   [Full Text] [Related]  

  • 71. Mutants of HIV-1 protease with enhanced stability to autodegradation.
    Tomasselli AG; Mildner AM; Rothrock DJ; Sarcich JL; Lull J; Leone J; Heinrikson RL
    Adv Exp Med Biol; 1995; 362():387-98. PubMed ID: 8540348
    [No Abstract]   [Full Text] [Related]  

  • 72. Site-directed mutagenesis of HIV-1 protease: generation of mutant proteases with increased stability to autodigestion.
    Tomasselli AG; Mildner AM; Rothrock DJ; Sarcich JL; Lull J; Leone J; Heinrikson R
    Adv Exp Med Biol; 1995; 362():473-7. PubMed ID: 8540360
    [No Abstract]   [Full Text] [Related]  

  • 73. Identification of amino acid residues of the retroviral aspartic proteinases important for substrate specificity and catalytic efficiency.
    Cameron CE; Burstein H; Bizub-Bender D; Ridky T; Weber IT; Wlodawer A; Skalka AM; Leis J
    Adv Exp Med Biol; 1995; 362():399-406. PubMed ID: 8540349
    [No Abstract]   [Full Text] [Related]  

  • 74. Mechanism of autoprocessing of a mini-precursor of the aspartic protease of human immunodeficiency virus type 1.
    Co E; Koelsch G; Hartsuck JA; Tang J
    Adv Exp Med Biol; 1995; 362():379-86. PubMed ID: 8540347
    [No Abstract]   [Full Text] [Related]  

  • 75. Cloning, isolation, expression and mutagenesis studies on the human immuno-deficiency virus type 1 (HIV-1) protease.
    Garner JC; Shoolingin-Jordan PM
    Biochem Soc Trans; 1998 Aug; 26(3):S287. PubMed ID: 9766006
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.